引用次数
引用: 56,979
H-指数: 88
I10-指数 : 222
出版物: 729
Colocalized Granular Cell Tumor and Infiltrating Ductal Carcinoma of the Breast
Hikmat Al-Ahmadie , Per-Olof Hasselgren , Rawia Yassin , George Mutema
Archives of Pathology & Laboratory Medicine 126 ( 6) 731 -733
30
2002
Rapamycin Pathway Markers in Urothelial Carcinoma of the Bladder: Possible Therapeutic Implications
H. Al-Ahmadie , M. I. Milowsky , N. Ishill , D. F. Bajorin
1
2011
Contribution of systemic and somatic factors to clinical response and resistance in urothelial cancer: an exploratory multi-omic analysis
Taha Merghoub , Hikmat Al-Ahmadie , Elaine R. Mardis , Dean F. Bajorin
bioRxiv 086843
2017
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
Isabel Alvarado-Cabrero , Hikmat A. Al-Ahmadie , Victor E. Reuter , Antonio Lopez-Beltran
PMC
2015
A phase III, randomized, open-label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (NIAGARA).
Hikmat A Al-Ahmadie , Thomas Powles , Joshua J Meeks , Hiroyuki Nishiyama
Journal of Clinical Oncology 37
4
2019
Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia
Hikmat A. Al-Ahmadie , Valerie Jakrot , James S. Wilmott , Rajmohan Murali
2016
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
Hikmat Al‐Ahmadie , Eugene J. Pietzak , Emily A. Vertosick , Guido Dalbagni
BJUI
2021
Comparison of genomic alterations in bladder urothelial tumors with and without telomerase reverse transcriptase promoter mutation using a next-generation sequencing assay.
Sumit Isharwal , Francois Audenet , Eugene J. Pietzak , Eugene K. Cha
Journal of Clinical Oncology 35 310 -310
1
2017
Patient derived xenografts of upper tract urothelial carcinoma: A potential tool for personalized medicine.
Jonathan Coleman , Kwanghee Kim , Katie S Murray , Aditya Bagrodia
Journal of Clinical Oncology 35 344 -344
2017
A Consensus Molecular Classification of Muscle-Invasive Bladder Cancer
Aurélie Kamoun , Aurélien de Reyniès , Yves Allory , Gottfrid Sjödahl
Social Science Research Network
7
2019
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Aurélie Kamoun , Aurélien de Reyniès , Yves Allory , Gottfrid Sjödahl
European Urology 77 ( 4) 420 -433
653
2020
The Immune Landscape of Cancer
Vésteinn Thorsson , David L. Gibbs , Scott D. Brown , Denise Wolf
Immunity 51 ( 2) 411 -412
229
2019
PD34-04 ACTIONABLE TARGETS IN PATIENTS WITH CISPLATIN-RESISTANT ADVANCED GERM CELL TUMORS
Aditya Bagrodia , Samuel Kaffenberger , Byron Lee , William Lee
The Journal of Urology 195 ( 4)
2016
PD42-06 DEFINING THE GENETIC EVOLUTION OF EPIGENETIC ALTERATIONS IN BLADDER CANCER
Timothy Clinton* , Hannah Wise , Nima Almassi , Shweta Chavan
The Journal of Urology 203
2020
PD47-01 GENOMIC DETERMINANTS OF NESTED VARIANT UROTHELIAL CARCINOMA
Timothy Clinton* , Karissa Whiting , Vitor Silva , Qiang Li
The Journal of Urology 203
2020
Abstract 602: Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
Neil B. Desai , Gopa Iyer , Eugene K. Cha , Sasinya N. Scott
Cancer Research 75 602 -602
2015
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
Anders S. Bjartell , Hikmat Al-Ahmadie , Angel M. Serio , James A. Eastham
Clinical Cancer Research 13 ( 14) 4130 -4138
79
2007
Targeted sequencing of upper tract urothelial carcinoma.
John P. Sfakianos , Philip H. Kim , Gopa Iyer , Eugene K. Cha
Journal of Clinical Oncology 32 309 -309
4
2014
Molecular Alterations in the Pathogenesis of Bladder Cancer Subtypes and Urothelial Carcinoma Variants
Hikmat Al-Ahmadie , Gopa Iyer
Molecular Pathology Library 65 -83
1
2018
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
Joshua D Campbell , Christina Yau , Reanne Bowlby , Yuexin Liu
Cell Reports 23 ( 1) 194
237
2018